Aurobindo Pharma has undergone a significant reorganisation, restructuring its operations into three subsidiaries. Eugia Pharma Specialitie...

According to a press release issued by the state government, the expansion is primarily targeted to ramp up the manufacturing of vaccines a...

The NYSE-listed, $2-billion drug maker by sales (2020), which is foraying into India's domestic formulations segment with focus on biologic...

In an interview to ET, Chirag Patel, Co-Chief Executive Officer of Amneal said that the company would hit the Indian market with its first ...

Akorn India, a subsidiary of the US-based Akorn Inc., has a manufacturing plant of 39,000 square metres over a 14-acre campus in Himachal P...

Hold Lupin Ltd. at a price target of Rs 760.0 .

While sustaining and growing its presence in the generics segment, Lupin is planning to invest heavily in developing high barrier products ...

"The Boards of Directors of both companies have approved the proposed acquisition, which is expected to close in the second half of 2017," ...

The business is expected to be valued at over $500 million and may also attract interest from a Chinese drugmaker and some Indian pharma co...

Gavis Pharma LLC is now exploring options to exit its listed Indian arm. Wintac Ltd was not part of the 2015 deal struck between Lupin & Ga...

Valuation is expected to be upwards of $500 million (Rs 3,400 crore), for which large generic drug makers and financial investors like glob...

Swedish contract drug manufacturing firm Recipharm has acquired a 74% stake in Nitin Lifesciences, a privately held sterile injectables man...

Strides Arcolab said it has completed the sale of its Agila Specialties division to Mylan Inc for a total consideration of up to $1.75 bill...

Claris Lifesciences Ltd, a parenteral drug company has received drug approval from US drug authorities for hypertension and angina treatmen...

The company had earlier acquired assets, improved efficiencies and subsequently sold them at attractive valuations.

Pfizer's discussions with Strides Arcolab to acquire the latter's unit, Agila Specialties , is at a fairly advanced stage.

Global drug-makers including Novartis and Pfizer are among ‘serious bidders’ considering bidding for Bangalore-based Strides Arcolabs injec...